Metagenomi (MGX) News Today $1.35 +0.04 (+3.05%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$1.36 +0.00 (+0.37%) As of 05/22/2026 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Wall Street Zen Downgrades Metagenomi (NASDAQ:MGX) to Strong SellMay 16, 2026 | americanbankingnews.comMetagenomi Therapeutics (MGX) price target decreased by 10.71% to 8.50May 14, 2026 | msn.comMetagenomi Therapeutics, Inc. (NASDAQ:MGX) Just Reported And Analysts Have Been Cutting Their EstimatesMay 14, 2026 | finance.yahoo.comMetagenomi, Inc. (NASDAQ:MGX) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMay 14, 2026 | americanbankingnews.comMetagenomi (NASDAQ:MGX) Given New $9.00 Price Target at Wells Fargo & CompanyMay 13, 2026 | americanbankingnews.comMetagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial ResultsMay 12, 2026 | markets.businessinsider.comMetagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Moderate Buy" by BrokeragesMay 9, 2026 | marketbeat.comMetagenomi (MGX) Projected to Post Quarterly Earnings on TuesdayMay 5, 2026 | marketbeat.comMetagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing ...April 16, 2026 | markets.businessinsider.comMetagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing EfficiencyApril 16, 2026 | globenewswire.comDid Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?April 13, 2026 | prnewswire.comMetagenomi Therapeutics: Q4 Earnings SnapshotMarch 5, 2026 | sfgate.comMetagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial ResultsMarch 5, 2026 | globenewswire.comMetagenomi Therapeutics, Inc. (MGX) Presents at TD Cowen 46th Annual Health Care Conference TranscriptMarch 4, 2026 | seekingalpha.comMetagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare ConferenceFebruary 23, 2026 | globenewswire.comMGX Resources Limited (MTGRY) Q2 2026 Earnings Call Prepared Remarks TranscriptFebruary 18, 2026 | seekingalpha.comIs Metagenomi Therapeutics (NASDAQ:MGX) In A Good Position To Deliver On Growth Plans?February 12, 2026 | finance.yahoo.comMGX Resources Limited (MTGRY) Shareholder/Analyst Call Prepared Remarks TranscriptJanuary 22, 2026 | seekingalpha.comMetagenomi, Inc.: Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate OutlookJanuary 12, 2026 | finanznachrichten.deMetagenomi Therapeutics Rebrands to Emphasize Therapeutic FocusJanuary 12, 2026 | tipranks.comMetagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate OutlookJanuary 12, 2026 | globenewswire.comMetagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature ConferenceDecember 1, 2025 | globenewswire.comMetagenomi (MGX) Price Target Decreased by 13.33% to 8.84November 18, 2025 | msn.comMetagenomi to Present at Jefferies Global Healthcare Conference in LondonNovember 17, 2025 | globenewswire.comMetagenomi culls 25% of its workforce and replaces CEO in reshuffleNovember 13, 2025 | finance.yahoo.comMetagenomi price target lowered to $7 from $11 at ChardanNovember 13, 2025 | msn.comMetagenomi, Inc. Reports Q3 2025 Financial ResultsNovember 12, 2025 | tipranks.comMetagenomi reports new dose range finding data from MGX-001 hemophilia A programNovember 11, 2025 | msn.comMetagenomi shares fall as company cuts workforce, changes CEONovember 11, 2025 | investing.comMetagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership UpdatesNovember 11, 2025 | globenewswire.comMetagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical DevelopmentNovember 11, 2025 | globenewswire.comMetagenomi to use Amazon's chips for gene-editing toolsOctober 22, 2025 | msn.comMetagenomi taps Amazon's custom chips to develop gene-editing toolsOctober 22, 2025 | reuters.comMetagenomi Regains Control After Affini-T Agreement TerminationOctober 1, 2025 | tipranks.comAbCellera appoints Sarah Noonberg as Chief Medical OfficerSeptember 10, 2025 | msn.comMetagenomi price target lowered to $11 from $12 at ChardanAugust 15, 2025 | msn.comMetagenomi, Inc. (MGX) Gets a Buy from TD CowenAugust 15, 2025 | theglobeandmail.comAnalysts Have Been Trimming Their Metagenomi, Inc. (NASDAQ:MGX) Price Target After Its Latest ReportAugust 15, 2025 | uk.finance.yahoo.comMetagenomi, Inc. Reports Q2 2025 Financial ResultsAugust 13, 2025 | msn.comMetagenomi Reports Strong Q2 2025 Financial ResultsAugust 12, 2025 | msn.comMetagenomi Reports Business Updates and Second Quarter 2025 Financial ResultsAugust 12, 2025 | globenewswire.comMetagenomi Appoints Laurence Reid, PhD to its Board of DirectorsAugust 11, 2025 | globenewswire.comMetagenomi (MGX) Presents Latest in Gene Editing TechnologiesJuly 29, 2025 | msn.comMetagenomi Showcases Advanced AI-Enhanced Gene Editing for Neurological Disorders at ASGCT MeetingJuly 14, 2025 | msn.comInsider Selling: Metagenomi, Inc. (NASDAQ:MGX) CEO Sells 10,785 Shares of StockJune 10, 2025 | insidertrades.comMetagenomi, Inc. (NASDAQ:MGX) Analysts Are Cutting Their Estimates: Here's What You Need To KnowMay 16, 2025 | finance.yahoo.com2MGX : Demystifying Metagenomi: Insights From 4 Analyst ReviewsMay 15, 2025 | benzinga.comMetagenomi Reports Promising Hemophilia A Study ResultsMay 14, 2025 | tipranks.comMetagenomi, Inc.: Metagenomi Reports Business Updates and First Quarter 2025 Financial ResultsMay 14, 2025 | finanznachrichten.deMetagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025May 14, 2025 | globenewswire.com Get Metagenomi News Delivered to You Automatically Sign up to receive the latest news and ratings for MGX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MGX Media Mentions By Week MGX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGX News Sentiment▼0.000.45▲Average Medical News Sentiment MGX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGX Articles This Week▼01▲MGX Articles Average Week Get the Latest News and Ratings for MGX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Metagenomi and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Moderna News Today Nkarta News Today Milestone Pharmaceuticals News Today Corbus Pharmaceuticals News Today Precision BioSciences News Today Tiziana Life Sciences News Today Tenaya Therapeutics News Today Oramed Pharmaceuticals News Today Lifecore Biomedical News Today Journey Medical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGX) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredJune 12: Elon Musk’s “Day-One Retirement Plan.”SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metagenomi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metagenomi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
